Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 20:08 UTC |
Ernest Opella FinleyDirector
|
GrantCommon Stock, $0.01 par value per share | 6,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000076 · wk-form4_1788466087.xml · nonDerivative · entry 1 Ernest Opella Finley · CIK 0002150873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,350 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting of Stockholders. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:01 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 21,275 | $27.67 | $588,679.25 |
DisclosureSEC source: 0001759655-26-000057 · wk-form4_1783972869.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,853 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 20:37 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 600 | $27.57 | $16,542.00 |
DisclosureSEC source: 0001858396-26-000016 · wk-form4_1783629474.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,128 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.55 to $27.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 53,722 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,274,622 Underlying: Common Stock, par value $0.01 per share · 53,722 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 53,722 | $27.24 | $1,463,387.28 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,188 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.09 to $27.39 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F4 · balance_after: Reflects the forfeiture of 8,463 unvested restricted stock units granted on May 20, 2026 under the Issuer's 2021 Omnibus Incentive Plan. Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 53,722 | $2.00 | $107,444.00 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 59,037 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,328,344 Underlying: Common Stock, par value $0.01 per share · 59,037 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 59,037 | $27.33 | $1,613,481.21 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,651 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 16:08 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 59,037 | $2.00 | $118,074.00 |
DisclosureSEC source: 0001401958-26-000010 · wk-form4_1783454906.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:06 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 24,734 | $27.50 | $680,185.00 |
DisclosureSEC source: 0001858396-26-000014 · wk-form4_1783454812.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,728 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.51 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 82,675 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · derivative · entry 9 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,387,381 Underlying: Common Stock, par value $0.01 per share · 82,675 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 37,041 | $26.93 | $997,514.13 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · nonDerivative · entry 5 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,651 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 45,634 | $26.52 | $1,210,213.68 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,692 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 82,675 | $2.00 | $165,350.00 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 52,823 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,470,056 Underlying: Common Stock, par value $0.01 per share · 52,823 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 52,823 | $25.72 | $1,358,607.56 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,651 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:04 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 52,823 | $2.00 | $105,646.00 |
DisclosureSEC source: 0001759655-26-000053 · wk-form4_1783022659.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 63,212 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,522,879 Underlying: Common Stock, par value $0.01 per share · 63,212 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 63,212 | $25.33 | $1,601,159.96 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,651 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.14 to $25.67 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 63,212 | $2.00 | $126,424.00 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 88,110 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,586,091 Underlying: Common Stock, par value $0.01 per share · 88,110 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 88,110 | $25.33 | $2,231,826.30 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,651 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.70 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:09 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 88,110 | $2.00 | $176,220.00 |
DisclosureSEC source: 0001759655-26-000048 · wk-form4_1782850154.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 8,897 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · derivative · entry 7 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,897 shares Expires 2028-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,336 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · derivative · entry 6 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 1,336 shares Expires 2029-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,001 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · derivative · entry 5 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 1,001 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,962 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · derivative · entry 4 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,962 shares Expires 2029-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 17,196 | $25.18 | $432,995.28 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,462 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:08 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.01 per share | 17,196 | $2.00 | $34,392.00 |
DisclosureSEC source: 0001759655-26-000046 · wk-form4_1782850077.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:26 UTC |
BERBERIAN LANCEDirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000043 · wk-form4_1779452780.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,131 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:24 UTC |
Ryu JaewonDirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000038 · wk-form4_1779452697.xml · nonDerivative · entry 1 Ryu Jaewon · CIK 0001869233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,110 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:25 UTC |
Morris Matthew ShawnDirector
|
GrantCommon Stock, par value $0.01 per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000039 · wk-form4_1779452714.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,651 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:26 UTC |
SOISTMAN FRANCIS S JRDirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000044 · wk-form4_1779452797.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,463 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:26 UTC |
COCOZZA NANCY GDirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000042 · wk-form4_1779452765.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,814 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:24 UTC |
KING DAVID PDirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000037 · wk-form4_1779452674.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,775 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:25 UTC |
McCarthy Thomas ADirector
|
GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000040 · wk-form4_1779452731.xml · nonDerivative · entry 1 McCarthy Thomas A · CIK 0001500886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,983 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 20, 2026 Filed May 22, 2026 12:25 UTC |
Kimmet Pamela ODirector
|
GrantCommon Stock, par value $0.01 per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000041 · wk-form4_1779452748.xml · nonDerivative · entry 1 Kimmet Pamela O · CIK 0001589981 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,172 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 12, 2026 Filed May 13, 2026 23:40 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 15,647 | $22.64 | $354,248.08 |
DisclosureSEC source: 0001759655-26-000030 · wk-form4_1778715628.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 434,357 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person Read SEC document |
| May 11, 2026 Filed May 13, 2026 23:40 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 105,439 | $22.55 | $2,377,649.45 |
DisclosureSEC source: 0001759655-26-000030 · wk-form4_1778715628.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450,004 F1 · kind: Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 11, 2026 Filed May 13, 2026 22:10 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 3,385 | $22.60 | $76,501.00 |
DisclosureSEC source: 0001858396-26-000011 · wk-form4_1778710217.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,462 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| May 04, 2026 Filed May 5, 2026 22:10 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,017 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000020 · wk-form4_1778019036.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,674,201 Underlying: Common Stock, par value $0.01 per share · 1,017 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| May 04, 2026 Filed May 5, 2026 22:10 UTC |
Morris Matthew ShawnDirector
|
SaleCommon Stock, par value $0.01 per share | 1,017 | $24.96 | $25,384.32 |
DisclosureSEC source: 0001759655-26-000020 · wk-form4_1778019036.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,188 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $24.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| May 04, 2026 Filed May 5, 2026 22:10 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionCommon Stock, par value $0.01 per share | 1,017 | $2.00 | $2,034.00 |
DisclosureSEC source: 0001759655-26-000020 · wk-form4_1778019036.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 360 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · derivative · entry 13 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,962 Underlying: Common Stock, par value $0.01 per share · 360 shares Expires 2029-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 592 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · derivative · entry 12 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,897 Underlying: Common Stock, par value $0.01 per share · 592 shares Expires 2028-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 52 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · derivative · entry 11 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,001 Underlying: Common Stock, par value $0.01 per share · 52 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 202 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · derivative · entry 10 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,336 Underlying: Common Stock, par value $0.01 per share · 202 shares Expires 2029-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 1,206 | $25.00 | $30,150.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · nonDerivative · entry 4 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,847 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| May 04, 2026 Filed May 6, 2026 00:07 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.01 per share | 1,206 | $2.00 | $2,412.00 |
DisclosureSEC source: 0001858396-26-000009 · wk-form4_1778026036.xml · nonDerivative · entry 3 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| May 01, 2026 Filed May 5, 2026 22:10 UTC |
Morris Matthew ShawnDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 17,096 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000020 · wk-form4_1778019036.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,675,218 Underlying: Common Stock, par value $0.01 per share · 17,096 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.